Process for the preparation of highly pure Salcaprozic Acid and pharmaceutically acceptable salts thereof
Processes that use novel reagents for the removal of colored impurity during the preparation of Salcaprozic Acid and pharmaceutically acceptable salts thereof. The processes include hydrolysis of 8-(2,4-dioxo-1,3-benzoxazin-3-yl)octanoic acid ethyl ester in the presence of or by contacting it with benzotriazole, hydrazine and/or sodium borohydride.
1. A process for the preparation of Salcaprozic Acid or a pharmaceutically acceptable salt thereof, comprising:
a. hydrolyzing a compound of formula II:
wherein, R is straight or branched chain alkyl
in the presence of benzotriazole, hydrazine, sodium borohydride or mixture thereof; and
b. isolating Salcaprozic Acid, which is free from colored impurity.
2. The process of claim 1 , wherein the compound of formula II is prepared from 1,3-Benzoxazine-2,4-dione and the compound of formula II is hydrolyzed in presence of about 0.1% to about 10% by weight of the benzotriazole, hydrazine, sodium borohydride or mixture thereof relative to weight of the 1,3-Benzoxazine-2,4-dione.
3. The process of claim 2 , wherein about 1% to about 5% by weight of the benzotriazole, hydrazine, sodium borohydride or mixture thereof is used relative to weight of the 1,3-Benzoxazine-2,4-dione.
4. The process of claim 1 , wherein the step of hydrolyzing in the presence of benzotriazole, hydrazine, sodium borohydride or mixture thereof occurs at ambient temperature.
5. The process of claim 2 , wherein the step of hydrolyzing comprises adding aqueous metal hydroxide and stirring at an elevated temperature up to about 95° C.
6. The process of claim 5 , further comprising cooling to 0-5° C. followed by adjusting pH to about 9 to about 10.
7. The process of claim 6 , further comprising washing the pH adjusted solution with an organic solvent followed by discarding the organic washing solvent.
8. The process of claim 7 , wherein the step of isolating comprises lowering pH of the washed solution to obtain a wet solid Salcaprozic Acid.
9. The process of claim 1 , further comprising filtering and washing the isolated Salcaprozic Acid with a mixture of acetone and water.
10. The process of claim 1 , further comprising contacting Salcaprozic Acid, which is free from colored impurity, with an organic or inorganic base in an organic solvent, water, or a mixture thereof to obtain a salt of Salcaprozic Acid.
11. The process of claim 10 , wherein absorbance at 400 nm of a 1% solution of the salt of Salcaprozic Acid is less than 0.03.
12. The process of claim 10 , wherein transmission at 600 nm of a 1% solution of the salt of Salcaprozic Acid is greater than 95%.
13. A process for removing a colored impurity from a Salcaprozic Acid salt comprising treating a solution of the salt with benzotriazole, hydrazine, sodium borohydride or a mixture thereof.
14. The process of claim 13 , wherein absorbance at 400 nm of a 1% solution of the treated salt is less than 0.03.
15. A process for the preparation of Salcaprozic Acid or a pharmaceutically acceptable salt thereof, comprising:
a. preparing 8-(2,4-dioxo-1,3-benzoxazin-3-yl)octanoic acid ethyl ester using 1,3-Benzoxazine-2,4-dione;
b. contacting the 8-(2,4-dioxo-1,3-benzoxazin-3-yl)octanoic acid ethyl ester with about 1% to about 5% by weight of benzotriazole, hydrazine, Sodium borohydride or mixture thereof relative to the amount of 1,3-Benzoxazine-2,4-dione,
c. adding aqueous metal hydroxide and stirring at an elevated temperature up to about 95° C.;
d. cooling to 0-5° C. followed by adjusting pH to about 9 to about 10;
e. washing the pH adjusted solution with an organic solvent to remove byproducts and impurities; and
f. lowering pH of the washed solution to isolate a wet solid Salcaprozic Acid.
16. The process of claim 15 , wherein the step of contacting occurs at ambient temperature.
17. The process of claim 15 , further comprising
g. filtering and washing the wet solid Salcaprozic Acid with a mixture of acetone and water to obtain purified Salcaprozic Acid.
18. The process of claim 17 , wherein an amount of any single impurity in the purified Salcaprozic Acid is less than 0.1%.
19. The process of claim 15 , wherein the Salcaprozic Acid is free of colored impurity.
20. The process of claim 15 , wherein 1% solution of a sodium salt of the wet Salcaprozic Acid has absorbance at 400 nm of less than 0.02 or transmission at 600 nm of greater than 99%.